AAOpt 2024: What's new in ocular drug delivery?

Commentary
Video

Dr. Justin Schweitzer's 2024 AAOpt talk will cover the latest advancements in ocular drug delivery, including topical, implant, and contact lens-based methods that can improve patient quality of life, adherence, and financial burden.

Optometrists are constantly seeking new and innovative ways to better serve patients. One area that has seen significant advancements in recent years is ocular drug delivery. At the upcoming 2024 American Academy of Optometry meeting in Indianapolis, Justin Schweitzer, OD, FAAO, and Walter Whitley, OD, MBA, FAAO, will be presenting a 50-minute session that delves into the latest developments in this critical field.

According to Schweitzer, a self-proclaimed "glaucoma guy," the session will cover a wide range of ocular drug delivery methods, from topical drops to implants placed directly within the eye. "We're excited to really dive into the different avenues of ocular drug delivery," he explains. "Whether it's from a glaucoma standpoint, with new implants being placed inside the eye, or advancements in retinal drug delivery, there's a lot of exciting progress happening." One area of particular interest is the role optometrists can play in these new drug delivery techniques and devices. "We want to discuss how optometry can be involved in these procedures and help our patients access these innovative solutions," Schweitzer says.

This is crucial, as many of these advancements have the potential to significantly improve patient quality of life and financial burden. "A big focus for us will be on how these new drug delivery methods can help patients who are struggling with adherence or the cost of their medications," Schweitzer explains. "If we can find ways to reduce the number of drops they need to take or provide longer-lasting solutions, it can make a real difference in their daily lives." The session will also touch on emerging technologies, such as the use of contact lenses for drug delivery. "There's some really interesting work being done with contact lenses that can deliver medications for glaucoma, dry eye, and even allergies," Schweitzer notes. "We'll be sure to give a brief overview of these advancements and what they could mean for our patients in the near future."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.